KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
Online PhD Defence Igor Popov
"Gut Microbiota Signatures in Artificial and Wildlife Models Related to Diet, Physiological State, and Rearing Environments of the Host"
23 Jun -
PhD Defence Habib Hasan Farooqui
"Measuring the potential impact of immunisation on demand for antibiotics and infectious disease-related out-of-pocket expenditure in India"
24 Jun -
PhD Defence Hedwig Martine Jose Maria Nies
"Advances in cardiac magnetic resonance imaging a paradigm shift from diagnostics to therapy"
25 Jun